Paragon 28 Past Earnings Performance
Past criteria checks 0/6
Paragon 28's earnings have been declining at an average annual rate of -52.1%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 18.5% per year.
Key information
-52.1%
Earnings growth rate
-49.0%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 18.5% |
| Return on equity | -40.3% |
| Net Margin | -22.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Analysts Have Made A Financial Statement On Paragon 28, Inc.'s (NYSE:FNA) Third-Quarter Report
Nov 15
It's Down 28% But Paragon 28, Inc. (NYSE:FNA) Could Be Riskier Than It Looks
Oct 03We Think Paragon 28 (NYSE:FNA) Has A Fair Chunk Of Debt
Sep 18Investors Give Paragon 28, Inc. (NYSE:FNA) Shares A 27% Hiding
Jun 24Is Paragon 28 (NYSE:FNA) Using Too Much Debt?
Jun 07Many Still Looking Away From Paragon 28, Inc. (NYSE:FNA)
Apr 17Paragon 28, Inc. (NYSE:FNA) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mar 03After Leaping 29% Paragon 28, Inc. (NYSE:FNA) Shares Are Not Flying Under The Radar
Nov 28Paragon 28 announces public offering of 6.5M shares
Jan 25Paragon 28 guides Q4 and FY22 revenue outlook above consensus
Jan 10Paragon 28 GAAP EPS of -$0.13 misses by $0.01, revenue of $46M beats by $3.52M
Nov 10US$25.00: That's What Analysts Think Paragon 28, Inc. (NYSE:FNA) Is Worth After Its Latest Results
May 12Revenue & Expenses Breakdown
How Paragon 28 makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 245 | -56 | 201 | 28 |
| 30 Jun 24 | 235 | -55 | 197 | 30 |
| 31 Mar 24 | 225 | -54 | 191 | 31 |
| 31 Dec 23 | 216 | -48 | 180 | 30 |
| 30 Sep 23 | 207 | -74 | 175 | 29 |
| 30 Jun 23 | 201 | -73 | 171 | 28 |
| 31 Mar 23 | 192 | -69 | 165 | 26 |
| 31 Dec 22 | 181 | -67 | 159 | 25 |
| 30 Sep 22 | 173 | -33 | 149 | 23 |
| 30 Jun 22 | 162 | -29 | 138 | 21 |
| 31 Mar 22 | 156 | -22 | 127 | 18 |
| 31 Dec 21 | 147 | -14 | 113 | 16 |
| 30 Sep 21 | 140 | -5 | 101 | 14 |
| 30 Jun 21 | 134 | 4 | 89 | 12 |
| 31 Mar 21 | 121 | 4 | 79 | 12 |
| 31 Dec 20 | 111 | 3 | 73 | 11 |
| 31 Dec 19 | 106 | 3 | 74 | 10 |
Quality Earnings: FNA is currently unprofitable.
Growing Profit Margin: FNA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FNA is unprofitable, and losses have increased over the past 5 years at a rate of 52.1% per year.
Accelerating Growth: Unable to compare FNA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FNA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: FNA has a negative Return on Equity (-40.27%), as it is currently unprofitable.